AI-generated summary
The authors report a case study of one patient with intermediate age-related macular degeneration and drusenoid pigment epithelium detachment who received photobiomodulation. A few weeks later, the detachment collapsed into retinal and outer retinal atrophy with worse visual acuity. The authors suggest that outer retinal thinning and posterior hypertransmission may be unfavorable prognostic signs for this treatment.
- Who or what was studied
- One patient with intermediate age-related macular degeneration and drusenoid pigment epithelium detachment
- Limits stated in the abstract
- The report describes a single patient, so no general conclusions can be drawn from it.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Age-related macular degeneration. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.